前列腺癌筛查与治疗的新建议。

New recommendations in prostate cancer screening and treatment.

作者信息

Adams Lisa K, Ferrington Lindsay S

机构信息

Lisa K. Adams practices hematology/oncology at Feist-Weiller Cancer Center in Shreveport, La., and is a recent graduate of the PA program at Louisiana State University's Health Sciences Center in Shreveport, La. Lindsay S. Ferrington is an instructor in the Louisiana State University PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2014 Aug;27(8):14-20; quiz 26. doi: 10.1097/01.JAA.0000451872.86566.bf.

DOI:10.1097/01.JAA.0000451872.86566.bf

PMID:24988136

Abstract

Prostate cancer is the most commonly diagnosed nonskin cancer in men, with 233,000 new cases estimated for 2014. Nearly 30,000 deaths are predicted for 2014, second only to lung and bronchial cancer deaths. Early diagnosis is key to improving patient survival rates. Screening efforts have dramatically increased the detection rate, and now, 90% of new diagnoses are caught at the early stage of disease. However, new data are driving controversial changes to screening and treatment recommendations.

摘要

前列腺癌是男性中最常被诊断出的非皮肤癌，预计2014年有23.3万新病例。预计2014年将有近3万人死亡，仅次于肺癌和支气管癌的死亡人数。早期诊断是提高患者生存率的关键。筛查工作显著提高了检出率，现在，90%的新诊断病例是在疾病早期发现的。然而，新数据正在推动对筛查和治疗建议产生有争议的变化。